Evidence map›Paper›PMID 38880906›Full record

ArticleBioelectronic medicine2024

Using neural biomarkers to personalize dosing of vagus nerve stimulation.

Antonin Berthon, Lorenz Wernisch, Myrta Stoukidi, Michael Thornton, Olivier Tessier-Lariviere, Pascal Fortier-Poisson, Jorin Mamen, Max Pinkney, Susannah Lee, Elvijs Sarkans and 13 more

Abstract read
In one paragraph

Article in Bioelectronic medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Antonin BerthonBIOS Health Ltd., Cambridge, UK. berthon.antonin@gmail.com.ORCID http://orcid.org/0000-0002-0200-0931
Lorenz WernischBIOS Health Ltd., Cambridge, UK.
Myrta StoukidiBIOS Health Ltd., Cambridge, UK.
Michael ThorntonBIOS Health Ltd., Cambridge, UK.
Olivier Tessier-LariviereBIOS Health Ltd., Cambridge, UK.
Pascal Fortier-PoissonBIOS Health Ltd., Cambridge, UK.
Jorin MamenBIOS Health Ltd., Cambridge, UK.
Max PinkneyBIOS Health Ltd., Cambridge, UK.
Susannah LeeBIOS Health Ltd., Cambridge, UK.
Elvijs SarkansBIOS Health Ltd., Cambridge, UK.
Luca AnnecchinoBIOS Health Ltd., Cambridge, UK.
Ben AppletonBIOS Health Ltd., Cambridge, UK.
Philip GarsedBIOS Health Ltd., Cambridge, UK.
Bret PattersonBIOS Health Ltd., Cambridge, UK.
Samuel GonshawBIOS Health Ltd., Cambridge, UK.
Matjaz JakopecBIOS Health Ltd., Cambridge, UK.
Sudhakaran ShunmugamBIOS Health Ltd., Cambridge, UK.
Tristan EdwardsBIOS Health Ltd., Cambridge, UK.
Aleksi TukiainenBIOS Health Ltd., Cambridge, UK.
Joel JenningsBIOS Health Ltd., Cambridge, UK.
Guillaume LajoieUniversité de Montréal and Mila-Quebec AI Institute, Montréal, Canada.
Emil HewageBIOS Health Ltd., Cambridge, UK.
Oliver ArmitageBIOS Health Ltd., Cambridge, UK.

Funding

Efficient mapping of neuromodulation therapy parameters to complex biomarker spacesOT2OD030536 · OD · BIOS HEALTH LTD · PI ARMITAGE, OLIVER · 2021 to 2022
$1.4M
National Institutes of Health (NIH) OT2OD030536NIH HHS OT2 OD030536
6 · The paper itself

Abstract

backgroundVagus nerve stimulation (VNS) is an established therapy for treating a variety of chronic diseases, such as epilepsy, depression, obesity, and for stroke rehabilitation. However, lack of precision and side-effects have hindered its efficacy and extension to new conditions. Achieving a better understanding of the relationship between VNS parameters and neural and physiological responses is therefore necessary to enable the design of personalized dosing procedures and improve precision and efficacy of VNS therapies.

methodsWe used biomarkers from recorded evoked fiber activity and short-term physiological responses (throat muscle, cardiac and respiratory activity) to understand the response to a wide range of VNS parameters in anaesthetised pigs. Using signal processing, Gaussian processes (GP) and parametric regression models we analyse the relationship between VNS parameters and neural and physiological responses.

resultsFirstly, we illustrate how considering multiple stimulation parameters in VNS dosing can improve the efficacy and precision of VNS therapies. Secondly, we describe the relationship between different VNS parameters and the evoked fiber activity and show how spatially selective electrodes can be used to improve fiber recruitment. Thirdly, we provide a detailed exploration of the relationship between the activations of neural fiber types and different physiological effects. Finally, based on these results, we discuss how recordings of evoked fiber activity can help design VNS dosing procedures that optimize short-term physiological effects safely and efficiently.

conclusionUnderstanding of evoked fiber activity during VNS provide powerful biomarkers that could improve the precision, safety and efficacy of VNS therapies.

Indexed as

BiomarkerHeart failureNeuromodulationVagus nerve stimulation

Identifiers

PMID38880906
PMCPMC11181600

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.